.On the heels of a $3 billion fund from Bain Capital Life Sciences, Arch Venture Allies is proving i...
.Finnish biotech Orion has snooped prospective in Aitia's "electronic twin" tech to establish new ca...
.While Windtree Rehabs has actually struggled to develop the monetary roots needed to have to surviv...
.OncoC4 is taking AcroImmune-- as well as its own in-house professional manufacturing abilities-- un...
.Amgen has discussed (PDF) the 1st phase 3 records on its own $400 thousand eczema drug, linking the...
.Biogen as well as UCB's rely on advancing into period 3 on the back of an unsuccessful research hop...
.Italian biotech Aptadir Therapies has launched with the pledge that its pipeline of preclinical RNA...
.Surge Life Sciences has actually fulfilled its own goal in a Duchenne muscle dystrophy (DMD) resear...
.After a few years in biotech, Mike Quigley, Ph.D., is returning to the pharma crease, occupying the...
.Achilles Therapeutics has actually destroyed its tactic. The British biotech is quiting working on ...